Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
2.870
+0.070 (2.50%)
At close: Sep 5, 2025, 4:00 PM
2.930
+0.059 (2.07%)
After-hours: Sep 5, 2025, 7:59 PM EDT
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $4.88 million as of September 5, 2025. Its market cap has increased by 185.85% in one year.
Market Cap
4.88M
Enterprise Value
-295.91K
1-Year Change
185.85%
Ranking
Category
Stock Price
$2.87
Market Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $4.88M, a decrease of -94.61%. That is a compound annual growth rate of -45.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 4.88M | 26.62% |
| Dec 31, 2024 | 3.85M | 22.18% |
| Dec 29, 2023 | 3.15M | -29.38% |
| Dec 30, 2022 | 4.46M | -93.27% |
| Dec 31, 2021 | 66.32M | -28.84% |
| Dec 31, 2020 | 93.20M | 2.97% |
| Nov 17, 2020 | 90.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 666.94B |
| Johnson & Johnson | 430.51B |
| AbbVie | 376.28B |
| UnitedHealth Group | 281.10B |
| AstraZeneca | 253.90B |
| Novo Nordisk | 249.80B |
| Novartis AG | 249.52B |
| Abbott Laboratories | 231.15B |